Brief: Idera Pharmaceuticals Inc Says By Decision Dated Jan 10, Nasdaq Panel Granted Co Extension Until Jan 20, To Complete Shareholder Meeting & Attendant Transactions

Aceragen

11/01/2023 13:38

Jan 11 (Reuters) - Idera Pharmaceuticals Inc  IDRA.O :
    * IDERA - BY DECISION DATED JAN 10, NASDAQ PANEL GRANTED CO
EXTENSION UNTIL JAN 20, TO COMPLETE  SHAREHOLDER MEETING &
ATTENDANT TRANSACTIONS
    * IDERA PHARMACEUTICALS INC - CO ANTICIPATES BEING ABLE TO
SATISFY
TERMS OF NASDAQ HEARING PANEL’S DECISION PRIOR TO JANUARY 20,
2023

Source text for Eikon:  ID: 
Further company coverage:  IDRA.O 
 ((reuters.briefs@thomsonreuters.com;))